A Post-marketing surveillance of ombitasvir/paritaprevir/ritonavir for patients with hepatitis C virus genotype 1b infection: A follow-up study of phase 2 and 3 clinical trials-Reference-Cited by-同舟云学术

A Post-marketing surveillance of ombitasvir/paritaprevir/ritonavir for patients with hepatitis C virus genotype 1b infection: A follow-up study of phase 2 and 3 clinical trials

Published:2022-07-01 Issue:7 Volume:63 Page:319-334
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Shimakami Tetsuro¹,Sakuma Ryuta²,Kawana Katsuyoshi²,Ohchi Kaoru²,Mochida Satoshi³,Kumada Hiromitsu⁴

Affiliation:

1. Department of Gastroenterology, Kanazawa University

2. Medical Division, AbbVie GK

3. Department of Gastroenterology and Hepatology, Saitama Medical University

4. Toranomon Hospital

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/63/7/63_319/_pdf

Reference31 articles.

1. 1) 田中純子, 栗栖あけみ, 秋田智之, 他. 厚生労働科学研究費補助金 (肝炎等克服政策研究事業) 令和元年度分担研究報告書: 肝炎ウイルス感染状況の把握及び肝炎ウイルス排除への方策に資する疫学研究: HBV/HCV持続感染者数の2000年以降の動向-NDBによるreal world解析を含めた推計-. https://mhlw-grants.niph.go.jp/system/files/2019/192161/201921003A_upload/201921003A0023.pdf (2021年11月22日参照)

2. 2) Matsuo J, Mizui M, Okita H, et al. Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years. Hepatol Res 2012; 42: 637-647

3. 3) Manns MP, Buti M, Gane E, et al. Hepatitis C virus infection. Nat Rev Dis Primers 2017; 3: 17006

4. 4) Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 2003; 71: 56-61

5. 5) 国立がん研究センター. がん情報サービス. https://ganjoho.jp/reg_stat/statistics/stat/summary.html (2021年11月22日参照)